Pulmonary ventilatory function decreases in proportion to increasing altitude.

The objective of this study was to examine how pulmonary ventilatory function, including response to bronchodilation, is related to altitude during high-altitude trekking. This cohort experiment consisted of multiple spirometric tests before and after bronchodilation in participants at baseline (1624 m) and at different altitudes (3404-4896 m) during a 2-week trek. The setting was in the Himalayas. Eleven men (ages 22-68 years) and eight women (ages 19-42 years) participated. Interventions were at altitudes of 1624 m to 5265 m; albuterol was administered via Rotahaler. Forced vital capacity (FVC) decreased by an average of 3.8% [95% confidence interval (CI) 1.6 to 6.0] per 1000-m altitude increment. Forced expiratory volume in 1 second (FEV1.0) decreased 3.7% (95% CI 1.9 to 5.5) per each 1000-m altitude increment. Maximal midexpiratory flow rate (FEF25-75%) decreased by 3.6% (95% CI 0.9 to 6.3) per each 1000-m altitude increment. Small, postalbuterol flow increases were present at baseline and at altitude. Ventilatory function returned quickly toward baseline upon descent. One trekker developed cough, dyspnea at rest, extreme weakness, rales, tachycardia, and oxygen desaturation to 71%. His ventilatory measurements did not differ significantly (p > 0.32) from the group means. We concluded that changes in some pulmonary ventilatory parameters (FVC, FEV1.0, and FEF25-75%) were proportional to the magnitude of altitude during a high-altitude trek. These were tolerated well and do not seem to relate to acute mountain sickness. A bronchodilator effect was not increased at altitude.

[1]  M. Miller,et al.  Effect of altitude on spirometric parameters and the performance of peak flow meters. , 1996, Thorax.

[2]  S. Anderson,et al.  Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .

[3]  Z. Tomori,et al.  Comparison of inspiratory effort in sniff-like aspiration reflex, gasping and normal breathing in cats. , 1993, The European respiratory journal.

[4]  Paul B. Rock,et al.  Acute Mountain Sickness , 1988 .

[5]  G. Ruppel.  Manual of Pulmonary Function Testing , 1987 .

[6]  J. Sutton,et al.  Changes in pulmonary PV characteristics of human subjects at an altitude of 5,366 m. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[7]  J. Maher,et al.  Evidence for increased intrathoracic fluid volume in man at high altitude. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[8]  G. Coates,et al.  Changes in lung volume, lung density, and distribution of ventilation during hypobaric decompression. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[9]  P. Hackett,et al.  THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS , 1976, The Lancet.

[10]  P. Curtis.  Letter: Medicine by remote control. , 1973, Lancet.

[11]  H. Rahn,et al.  Adaption to High Altitude: Changes in Lung Volumes During the First Seven Days at Mt. Evans, Colorado , 1953 .

[12]  H. Rahn,et al.  Vital capacity at reduced barometric pressure. , 1952, Journal of applied physiology.

[13]  P. Wagner,et al.  Operation Everest. II: Spirometric and radiographic changes in acclimatized humans at simulated high altitudes. , 1993, The American review of respiratory disease.

[14]  R. Mccullough,et al.  Pulmonary function and hypoxic ventilatory response in subjects susceptible to high-altitude pulmonary edema. , 1993, Chest.

[15]  C. Houston,et al.  The relationship between acute mountain sickness and pulmonary ventilation at 2,835 meters (9,300 ft). , 1979, Chest.